- Home
- NRIM vs RNAC Comparison
NRIM vs RNAC Comparison
Compare NRIM & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- RNAC
- Stock Information
- Founded
- NRIM 1990
- RNAC 2007
- Country
- NRIM United States
- RNAC United States
- Employees
- NRIM N/A
- RNAC N/A
- Industry
- NRIM Savings Institutions
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- NRIM Finance
- RNAC Health Care
- Exchange
- NRIM Nasdaq
- RNAC Nasdaq
- Market Cap
- NRIM 474.2M
- RNAC 422.4M
- IPO Year
- NRIM N/A
- RNAC 2016
- Fundamental
- Price
- NRIM $84.00
- RNAC $18.10
- Analyst Decision
- NRIM
- RNAC Strong Buy
- Analyst Count
- NRIM 0
- RNAC 7
- Target Price
- NRIM N/A
- RNAC $41.60
- AVG Volume (30 Days)
- NRIM 24.3K
- RNAC 113.3K
- Earning Date
- NRIM 01-23-2025
- RNAC 11-07-2024
- Dividend Yield
- NRIM 2.88%
- RNAC N/A
- EPS Growth
- NRIM 22.45
- RNAC N/A
- EPS
- NRIM 5.86
- RNAC N/A
- Revenue
- NRIM $141,590,000.00
- RNAC $47,938,000.00
- Revenue This Year
- NRIM N/A
- RNAC $56.06
- Revenue Next Year
- NRIM $3.03
- RNAC N/A
- P/E Ratio
- NRIM $14.67
- RNAC N/A
- Revenue Growth
- NRIM 12.70
- RNAC N/A
- 52 Week Low
- NRIM $43.92
- RNAC $11.67
- 52 Week High
- NRIM $91.72
- RNAC $41.87
- Technical
- Relative Strength Index (RSI)
- NRIM 51.76
- RNAC 40.64
- Support Level
- NRIM $83.29
- RNAC $17.72
- Resistance Level
- NRIM $89.11
- RNAC $26.50
- Average True Range (ATR)
- NRIM 2.54
- RNAC 2.26
- MACD
- NRIM -0.89
- RNAC -0.45
- Stochastic Oscillator
- NRIM 5.84
- RNAC 0.00
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.